Within your trust how many patients have been treated, in the past 6 months January to June, 2017 by diagnosed eye condition. Of these patients how many are new to treatment [they have not previously received an injection /implant]?
|Total Patients||New Patients||Lucentis (ranibizumab) Patients||Lucentis (ranibizumab) NEW Patients||Eylea (aflibercept) Patients||Eylea (aflibercept) NEW Patients
|Wet Age Related Macular Degeneration (wAMD)|
|Other conditions (DMO, RVO or mCNV)|
*Royal Surrey County Hospital NHS Foundation Trust does not record centrally the indication for treatment and therefore can only provide total number of patients treated with the above medicines for any indication for a specified time period. To do so would require manually extracting the information from each patient healthcare record which would take above and beyond the timeframe specified under Section 12 of the Freedom of Information Act.